Oliver Hvidt is the founder of Norlase. Norlase has raised $33M in total funding. Latest round: Series C. Based in Ballerup, Denmark.
Oliver Hvidt is the Co-founder and CEO of Norlase, a med-tech company that develops next-generation ophthalmic laser technology for treating retina and glaucoma diseases. Norlase secured €20 million in venture debt financing from the European Investment Bank in February 2025 and previously raised $11 million in May 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library